Bextra and Magnesium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bextra (valdecoxib) and Magnesium (magnesium). Common drug interactions include arthralgia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Bextra and Magnesium. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Bextra?

Bextra has active ingredients of valdecoxib. It is often used in pain. eHealthMe is studying from 20,994 Bextra users. Check the latest studies of Bextra.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,144 Magnesium users. Check the latest studies of Magnesium.

On Jul, 18, 2026

56 people who take Bextra and Magnesium together, and have interactions are studied.

What are the common drug interactions of Bextra and Magnesium, by gender? *:

female:

Arthralgia (joint pain)
Bone disorder
Intervertebral disc protrusion (spinal disc protrusion)
Chest pain
Urinary retention (the inability to completely or partially empty the bladder)
Decreased appetite
Hypoaesthesia (reduced sense of touch or sensation)
Joint effusion (presence of extra fluid in joint covering)
Mouth ulceration (mouth ulcers)
Neuritis (inflammation of nerve)

male:

Anxiety
Injury
Bacteraemia (presence of bacteria in the blood)
Bone disorder
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Deformity (disfigurement)
Febrile neutropenia (fever with reduced white blood cells)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypercholesterolaemia (high levels of cholesterol in the blood)

What are the common drug interactions of Bextra and Magnesium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
Adenoma benign (non-cancerous tumour -secreting)
Adnexa uteri cyst (ovarian cysts)
Allergic sinusitis
Anxiety
Aortic arteriosclerosis (hardening of the aortic arteries)
Aortic calcification (aortic calcification sign of heart valve disease)
Aortic valve sclerosis (narrowing of the aortic valve)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)

30-39:

n/a

40-49:

Dyspnoea (difficult or laboured respiration)
Hyperlipidaemia (presence of excess lipids in the blood)
Abdominal distension
Abdominal pain
Anaemia (lack of blood)
Anxiety
Bacteraemia (presence of bacteria in the blood)
Bone disorder
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

50-59:

Cardiac failure congestive
Hepatic cyst
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Spinal osteoarthritis (joint cartilage loss in spine)
Abdominal pain
Acquired oesophageal web (structural abnormalities in the oesophagus)
Anxiety
Bone disorder
Breast cancer recurrent
Cellulitis (infection under the skin)

60+:

Bone disorder
Dizziness
Osteosclerosis (an elevation in bone density)
Rash
Rib fracture
Urinary retention (the inability to completely or partially empty the bladder)
Actinomycosis (infection that causes sores, or abscesses)
Alopecia (absence of hair from areas of the body)
Asthenia (weakness)
Atelectasis (partial or complete collapse of the lung)

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 15 people, 26.79%
High Blood Pressure: 11 people, 19.64%
Multiple Myeloma (cancer of the plasma cells): 9 people, 16.07%
Hypersensitivity: 9 people, 16.07%
Depression: 8 people, 14.29%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 7 people, 12.50%
Menopause (end of monthly cycles in women): 7 people, 12.50%
Back Pain: 7 people, 12.50%
Insomnia (sleeplessness): 7 people, 12.50%
Sinus Disorder (disease of sinus): 7 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Bextra and Magnesium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously